Research Article
A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis
Table 1
Clinical characteristics of study participants. Patient characteristics.
| | All patients () |
| Gender | | Male | 199 (68.86) | Female | 90 (31.14) | Age (years) | 55.96 (13.15) | BMI (kg/m2) | 22 (3.07) | Hypertension | 27 (9.34) | Diabetes | 36 (12.46) | HB (g/L) | 99.5 (27.6) | WBC (×109/L) | 4.36 (2.28) | Use of NSBB | 189 (65.4) | PTV | 36 (12.46) | AST (IU/L) | 35 (26-52.5) | ALT (IU/L) | 24 (16-40.5) | Platelet count (×109/L) | 71 (46-121.5) | Total bilirubin (μmol/L) | 19.5 (12.8-29.6) | Albumin (g/L) | 34.7 (6.08) | ALP (IU/L) | 88 (62-130) | GGT (IU/L) | 32 (19-74) | Baseline LSM (kPa) | 14.25 (10.58-19.13) | PT (second) | 13.6 (12.6-14.8) | INR | 1.21 (1.11-1.33) | Fibrinogen (g/L) | 1.97 (1.15) | Cr (μmol/L) | 65.5 (55.8-77.9) | BUN (mmol/L) | 5.9 (5.19) | HBeAg | 59 (20.41) | HBV DNA (log10 IU/mL) | | Portal vein diameter (cm) | 1.5 (1.3-1.6) | MELD score | 9.04 (8.126-11.17) | Child-Pugh class | | A | 264 (91.35) | B | 25 (8.65) |
|
|
Continuous variables are expressed as mean (standard deviation) or median (interquartile range); categorical variables are expressed as number (percentage). BMI: body mass index; HB: hemoglobin; WBC: white blood cell; PVT: portal vein thrombosis; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; LSM: liver stiffness measurement; INR: international normalized ratio; Cr: creatinine BUN: blood urea nitrogen; PT: prothrombin time.
|